logo TNO logo TNO innovation for life
  • Advanced search
  • How to search
  • About
  • Contact
  • EN
    • Nederlands
    • English

The 5TMM series: A useful in vivo mouse model of human multiple myeloma

article
2000




Asosingh, K.

Radl, J.

Riet, I. van

Camp, B. van

Kerken, K. van der
Chemicals/CAS: Cancer Vaccines; Myeloma Proteins; pristane, 1921-70-6; Terpenes; Vaccines, DNA
Topics











































5TMMModelsMyelomacancer vaccineDNA vaccineparaproteinpristaneBagg albino mouseC57BL mousechemically induced disorderchromosome aberrationcomparative studydisease modelgeneticsmousemouse mutantmultiple myelomaoncogene mycparaproteinemiapathologyperitoneum tumorplasmacytomareviewxenograftAnimalsCancer VaccinesChromosome AberrationsDisease Models, AnimalGenes, mycHumansMiceMice, Inbred BALB CMice, Inbred C57BLMice, SCIDMultiple MyelomaMyeloma ProteinsOsteolysisParaproteinemiasPeritoneal NeoplasmsPlasmacytomaTerpenesTransplantation, HeterologousVaccinationVaccines, DNA
TNO Identifier
235859
Repository link
https://resolver.tno.nl/uuid:fe6d137e-6042-4c23-8338-bfd9090d824e
ISSN
14664860
Source
Hematology Journal, 1(5), pp. 351-356.
Pages
351-356
Files
To receive the publication files, please send an e-mail request to TNO Repository.

This is what we're working on

  • Sustainable
  • Healthy
  • Safe
  • Digital
  • Sectors
  • Careers
  • Newsroom

    • News
    • Events
    • Webinars
    • Insights
    • Podcasts
    • Subscribe to our TNO Update
  • About TNO

    • Mission and vision
    • Strategy
    • Organisation
    • Our people
    • Contact
    • TNO and society
    • Communities
  • Technology and science

    • Labs
    • Technologies
    • Patents and licenses
    • Repository TNO Publications
  • Collaboration

    • Projects on commission
    • Public-private
    • SME
    • Tech Transfer
    • International

Make TNO yours!

Follow your favorite subjects.

Create your own TNO News
TNO innovation for life
  • Cookies
  • Privacy statement
  • Accessibility
  • Disclaimer
  • General terms and conditions
  • English
  • Nederlands
  • LinkedIn
  • Facebook
  • X
  • Youtube
  • Instagram